Skip to main content
. 2018 May 8;13(5):e0196780. doi: 10.1371/journal.pone.0196780

Fig 1. Comparison of levels of cell adhesion molecules between good and poor responders to bortezomib plus dexamethasone (Bd) therapy.

Fig 1

(A) Comparison of the expression of several genes associated with cell adhesion molecules among good responders (CR+VGPR+PR) and poor responders (SD+PD) to Bd therapy. (B) Comparison of cell-surface expression of NCAM by FACS among the good and poor responders to Bd therapy. * indicates statistical significance (p < 0.05) as calculated by a Mann–Whitney U test.